Completed
OBSERVATIONAL
NCT01578135
French National Registry of Children Born Small for Gestational Age Treated With Somatropin
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
This study is conducted in Europe. The aim of the study is to describe the patient population and therapeutic practices (study phase I), assess efficacy on growth and adult height and assess tolerance of somatropin (Norditropin® SimpleXx®) (study phase II)
Interventions
Name:
somatropin
Type:
DRUG
Description:
Patients are to fill in a questionnaire at inclusion in registry
Name:
somatropin
Type:
DRUG
Description:
Patients are to fill in a questionnaire 6 months after inclusion into registry and then annually until adult height is reached
Primary Outcomes
Measure:
Growth in height
TimeFrame:
6 months after inclusion into registry and then annually until adult height is reached
Description:
Trial Information
NCT ID
NCT01578135
Status
Completed
Study Type
OBSERVATIONAL
Sponsor
Novo Nordisk A/S
Last Updated
December 15, 2025